[1] |
NG S C, SHI H Y, HAMIDI N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. The Lancet, 2017, 390(10114): 2769-2778. DOI: 10.1016/S0140-6736(17)32448-0.
|
[2] |
KAPLAN G G. Colon cancer in Asian patients with ulcerative colitis[J]. The Lancet Gastroenterology & Hepatology, 2017, 2(4): 238-239. DOI: 10.1016/S2468-1253(17)30032-8.
|
[3] |
OLÉN O, ERICHSEN R, SACHS M C, et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study[J]. Lancet, 2020, 395(10218): 123-131. DOI: 10.1016/S0140-6736(19)32545-0.
pmid: 31929014
|
[4] |
LAHARIE D. Towards therapeutic choices in ulcerative colitis[J]. Lancet, 2017, 390(10090): 98-99. DOI: 10.1016/S0140-6736(17)31263-1.
pmid: 28527707
|
[5] |
DANESE S, FIOCCHI C. Ulcerative colitis[J]. New England Journal of Medicine, 2011, 365(18): 1713-1725. DOI: 10.1056/nejmra1102942.
|
[6] |
MOURÃO L R M B, SANTANA R S S, PAULO L M, et al. Protective action of indole-3-acetic acid on induced hepatocarcinoma in mice[J]. Cell Biochemistry and Function, 2009, 27(1): 16-22. DOI: 10.1002/cbf.1528.
pmid: 19107877
|
[7] |
TINTELNOT J, XU Y, LESKER T R, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer[J]. Nature, 2023, 615(7950): 168-174. DOI: 10.1038/s41586-023-05728-y.
|
[8] |
HENDRIKX T, DUAN Y, WANG Y H, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice[J]. Gut, 2019, 68(8): 1504-1515. DOI: 10.1136/gutjnl-2018-317232.
pmid: 30448775
|
[9] |
YANG C C, DU Y, REN D Y, et al. Gut microbiota-dependent catabolites of tryptophan play a predominant role in the protective effects of turmeric polysaccharides against DSS-induced ulcerative colitis[J]. Food & Function, 2021, 12(20): 9793-9807. DOI: 10.1039/d1fo01468d.
|
[10] |
WANG Y, JI X G, ZHAO M Y, et al. Modulation of tryptophan metabolism via AHR-IL22 pathway mediates the alleviation of DSS-induced colitis by chitooligosaccharides with different degrees of polymerization[J]. Carbohydrate Polymers, 2023, 319: 121180. DOI: 10.1016/j.carbpol.2023.121180.
|
[11] |
YANG W Q, REN D Y, SHAO H J, et al. Theabrownin from fu brick tea improves ulcerative colitis by shaping the gut microbiota and modulating the tryptophan metabolism[J]. Journal of Agricultural and Food Chemistry, 2023, 71(6): 2898-2913. DOI: 10.1021/acs.jafc.2c06821.
pmid: 36728562
|
[12] |
ZHANG X N, SHI L, WANG N, et al. Gut bacterial indole-3-acetic acid induced immune promotion mediates preventive effects of fu brick tea polyphenols on experimental colitis[J]. Journal of Agricultural and Food Chemistry, 2023, 71(2): 1201-1213. DOI: 10.1021/acs.jafc.2c06517.
pmid: 36621895
|
[13] |
ESSER C, RANNUG A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology[J]. Pharmacological Reviews, 2015, 67(2): 259-279. DOI: 10.1124/pr.114.009001.
pmid: 25657351
|
[14] |
GUTIÉRREZ-VÁZQUEZ C, QUINTANA F J. Regulation of the immune response by the aryl hydrocarbon receptor[J]. Immunity, 2018, 48(1): 19-33. DOI: 10.1016/j.immuni.2017.12.012.
|
[15] |
CAI J, SUN L L, GONZALEZ F J. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis[J]. Cell Host & Microbe, 2022, 30(3): 289-300. DOI: 10.1016/j.chom.2022.02.004.
|
[16] |
黄志斌. 肠道菌群代谢产物吲哚丙酸部分激活芳香烃受体促进巨噬细胞吞噬减轻脓毒症损伤[D]. 广州: 南方医科大学, 2022.
|
[17] |
姜旭, 杨华夏, 张奉春. 肠道菌群代谢产物在自身免疫性疾病中的作用[J]. 协和医学杂志, 2022, 13(5): 747-752. DOI: 10.12290/xhyxzz.2022-0246.
|
[18] |
穆燕菊, 罗娟, 缪应雷. 基于肠道菌群参与的炎症性肠病色氨酸代谢的研究进展[J]. 国际消化病杂志, 2022, 42(3): 141-145. DOI: 10.3969/j.issn.1673-534X.2022.03.001.
|
[19] |
SLIFER Z M, BLIKSLAGER A T. The integral role of tight junction proteins in the repair of injured intestinal epithelium[J]. International Journal of Molecular Sciences, 2020, 21(3): 972. DOI: 10.3390/ijms21030972.
|
[20] |
BERTIN S, AOKI-NONAKA Y, LEE J, et al. The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1[J]. Gut, 2017, 66(9): 1584-1596. DOI: 10.1136/gutjnl-2015-310710.
|
[21] |
BRITTON G J, CONTIJOCH E J, MOGNO I, et al. Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORγt+ regulatory T cells and exacerbate colitis in mice[J]. Immunity, 2019, 50(1): 212-224.e4. DOI: 10.1016/j.immuni.2018.12.015.
|